HPV sabotages IVF
Human papillomavirus (HPV) lowers IVF success by more than 50%, according to the findings of a prospective study of 106 women.
Human papillomavirus (HPV) lowers IVF success by more than 50%, according to the findings of a prospective study of 106 women.
Sixteen percent of the women in the study tested positive for HPV using the Digene Hybrid Capture II assay, which detects the 13 most common high-risk and the five most common low-risk HPV variants. The women with HPV were less than half as likely as the women without the virus to become pregnant (23.5% vs. 57%; P<0.02).
Whether the infection directly affects fertility or whether it is indicative of an underlying immunologic deficiency remains a subject for investigation.
The benefits of concurrent fetal and maternal heart rate monitoring
April 15th 2024A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Read More
How vitamin C intake in pregnant smokers impacts offspring airway function trajectory
April 12th 2024Investigating the impact of prenatal vitamin C supplementation on lung function and wheeze occurrence in offspring of pregnant smokers, revealing insights into mitigating respiratory risks.
Read More
NAID report shows maternal COVID-19 vaccination protects newborns
April 4th 2024New research led by the National Institute of Allergy and Infectious Diseases reveals sustained antibody levels in infants born to vaccinated mothers, underscoring the importance of maternal vaccination in safeguarding newborns against COVID-19.
Read More
FDA grants FTD to nipocalimab for treating FNAIT
March 26th 2024The FDA's Fast Track Designation for nipocalimab marks a significant step in addressing fetal neonatal alloimmune thrombocytopenia risk in pregnant patients, potentially revolutionizing treatment for this severe condition with unmet medical needs.
Read More
